Related Experiment Video

Updated: Aug 9, 2026

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1

F Fallarino1, T F Gajewski

  • 1Department of Pathology, Department of Medicine, Section of Hematology/Oncology, University of Chicago, IL 60637, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|October 8, 1999
PubMed

Insights

Interferon-gamma (IFN-γ) signaling on host immune cells is crucial for developing effective anti-tumor immunity. Stat1-deficient mice demonstrate impaired tumor rejection and reduced effector cell function, highlighting IFN-γ

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Signaling

Background:

  • Evidence suggests a Th1/Tc1 phenotype producing interferon-gamma (IFN-γ) is optimal for tumor rejection.
  • IFN signaling on tumor cells is known to protect against carcinogenesis.
  • The role of IFN signaling in host immune cells for anti-tumor responses remains underexplored.

Purpose of the Study:

  • To investigate the role of IFN-γ-mediated signaling in host immune cells for anti-tumor immunity.
  • To determine if IFN signaling on host cells is required for the development of anti-tumor effector cells.

Main Methods:

  • Utilized Stat1-deficient (Stat1-/-) mice as tumor recipients.
  • Administered an IL-12-based vaccine to assess tumor regression.
  • Analyzed T cell and Natural Killer (NK) cell production of IFN-γ and cytolytic activity.

Main Results:

  • Stat1-/- mice failed to reject immunogenic tumors and showed no regression of poorly immunogenic tumors post-vaccination.
  • T cells from immunized Stat1-/- mice produced significantly less IFN-γ and lacked cytolytic activity compared to wild-type.
  • NK cell lytic activity was absent in Stat1-/- mice, correlating with a failure to up-regulate serine esterase activity.

Conclusions:

  • IFN-γ-mediated signaling on host immune cells is essential for developing anti-tumor effector cell function.
  • Stat1 signaling is required for the generation of cytolytic T cells and NK cells capable of tumor rejection.
  • These findings underscore the importance of host IFN signaling pathways in anti-cancer immune responses.

More Related Videos

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 8, 2019

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.